Mario Eisenberger


1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mario Eisenberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

    Hasan, H., Deek, M. P., Phillips, R., Hobbs, R. F., Malek, R., Radwan, N., Kiess, A. P., Dipasquale, S., Huang, J., Caldwell, T., Leitzel, J., Wendler, D., Wang, H., Thompson, E., Powell, J., Dudley, S., Deville, C., Greco, S. C., Song, D. Y., Deweese, T. L. & 11 others, Gorin, M. A., Rowe, S. P., Denmeade, S., Markowski, M., Antonarakis, E. S., Carducci, M. A., Eisenberger, M. A., Pomper, M. G., Pienta, K. J., Paller, C. J. & Tran, P. T., Jun 1 2020, In : BMC cancer. 20, 1, 492.

    Research output: Contribution to journalArticle

    Open Access
  • Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer

    Halabi, S., Dutta, S., Tangen, C. M., Rosenthal, M., Petrylak, D. P., Thompson, I. M., Chi, K. N., De Bono, J. S., Araujo, J. C., Logothetis, C., Eisenberger, M. A., Quinn, D. I., Fizazi, K., Morris, M. J., Higano, C. S., Tannock, I. F., Small, E. J. & Kelly, W. K., Jul 2020, In : Annals of Oncology. 31, 7, p. 930-941 12 p.

    Research output: Contribution to journalArticle

  • Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials

    Robbrecht, D. G., Delanoy, N., Tannock, I. F., Tombal, B., Eisenberger, M., Fizazi, K., Sartor, O., Mercier, F., Oudard, S. & de Wit, R., Jan 2020, In : European Journal of Cancer. 125, p. 142-152 11 p.

    Research output: Contribution to journalArticle

    Open Access